Untitled - Roche Trasplantes

BIOPSIA DE PROTOCOLO EN EL TRASPLANTE RENAL
13. Koch CA, Khalpey ZI, Platt JL. Accommodation: preventing injury in transplantation
and disease. J Immunol 2004; 172 (9): 5143-8.
14. Lederer SR, Kluth-Pepper B, Schneeberger H, Albert E, Land W, Feucht HE. Impact
of humoral alloreactivity early after transplantation on the long-term survival of renal
allografts. Kidney Int 2001; 59 (1): 334-41.
15. Liptak P, Kemeny E, Morvay Z, Szederkenyi E, Szenohradszky P, Marofka F, et al.
Peritubular capillary damage in acute humoral rejection: an ultrastructural study on
human renal allografts. Am J Transplant 2005; 5 (12): 2870-6.
16. Magil AB, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal
allograft rejection. Kidney Int 2003; 63 (5): 1888-93.
17. Mauiyyedi S, Pelle PD, Saidman S, Collins AB, Pascual M, Tolkoff-Rubin NE, et al.
Chronic humoral rejection: identification of antibody-mediated chronic renal allograft
rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12 (3):
574-82.
18. Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, et
al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology,
and pathologic classification. J Am Soc Nephrol 2002; 13 (3): 779-87.
19. Mengel M, Bogers J, Bosmans J-L, Serón D, Moreso F, Carrera M, et al Incidence of
C4d Stain in Protocol Biopsies from Renal Allografts: Results from a Multicenter Trial.
Am J Transplant 2005; 5 (5): 1050-6.
20. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ. Detection of the complement
degradation product C4d in renal allografts: diagnostic and therapeutic implications.
J Am Soc Nephrol 2002; 13 (1): 242-51.
21. Pascual MA, Crespo M, Tolkoff-Rubin N. Progress in understanding humoral rejection
in kidney transplantation: implications for patient management. Nefrologia 2001; 21
(4): 327-31.
22. Platt JL. C4d and the fate of organ allografts. J Am Soc Nephrol 2002; 13 (9): 2417-9.
23. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, et al.
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal
allograft rejection. Am J Transplant 2003; 3 (6): 708-14.
24. Regele H, Bohmig GA, Habicht A, Gollowitzer D, Schillinger M, Rockenschaub S,
et al. Capillary deposition of complement split product C4d in renal allografts is associated
with basement membrane injury in peritubular and glomerular capillaries:
a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol
2002; 13 (9): 2371-80.
25. Regele H, Exner M, Watschinger B, Wenter C, Wahrmann M, Osterreicher C, et
al. Endothelial C4d deposition is associated with inferior kidney allograft outcome
independently of cellular rejection. Nephrol Dial Transplant 2001; 16 (10): 2058-
66.
26. Stegall MD, Gloor J, Winters JL, Moore SB, Degoey S. A Comparison of Plasmapheresis
versus High-Dose IVIG Desensitization in Renal Allograft Recipients with High Levels
of Donor Specific Alloantibody. Am J Transplant 2006; 6 (2): 346-51.
68